Market Closed -
Other stock markets
|
Pre-market 05:24:30 pm | |||
867.3 USD | +0.17% | 869.2 | +0.22% |
12/06 | Eli Lilly Gets FDA Approval for Selpercatinib to Treat Thyroid Cancer | MT |
12/06 | Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.79% | 78TCr | |
+41.54% | 64TCr | |
+19.43% | 33TCr | |
+7.18% | 29TCr | |
+17.28% | 25TCr | |
-0.12% | 22TCr | |
+11.37% | 22TCr | |
+4.53% | 16TCr | |
-3.92% | 16TCr | |
-1.18% | 12TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study